November 21, 2024
9-10am EST/ 3-4pm CET
As the world faces rising levels of antimicrobial resistance (AMR), the disparities in access to essential antimicrobials have become more apparent, particularly in low- and middle-income countries. At the same time, numerous regions grapple with conflict, and it is critical to understand how the disruption of health systems and the displacement of populations, with a disproportionate percentage being women and children, further impede global action on AMR.
Join us for a thought-provoking online panel on equity and access to antimicrobials hosted by the AMR Policy Accelerator and the Center on Forced Displacement in recognition of World AMR Awareness Week 2024. This event will feature experts with firsthand experience in addressing barriers to access to antimicrobials, drawing perspectives from both patients and health systems to explore how geography, gender, and systemic inequities are exacerbating health outcomes in vulnerable populations.
The format of this webinar will include a short presentation on new research followed by commentary from panelists and a moderated Q&A session.
This webinar will be recorded and shared with registrants. If you require support to cover data accessibility costs, please contact contact@globalstrategylab.org.
Moderator & Panelists
Dr. Muhammad Zaman
Director, Center on Forced Displacement
Muhammad Hamid Zaman is Howard Hughes Medical Institute Professor of Biomedical Engineering and Global Health at Boston University and inaugural Director of Center on Forced Displacement at Boston University. His work focuses on, among other things, understanding the drivers of drug resistant infections among forcibly displaced communities in camps, urban centers and informal settlements.
Dr. Angela Uyen Cateriano
Health Policy Advisor, Médecins Sans Frontières
Dr. Angela Uyen Cateriano is a medical doctor with experience in different contexts and areas of global health and particularly on infection control. She is an experienced project manager and consultant and has been working with MSF since 2009. Angela also holds a master’s degree in infectious diseases control, a master’s of business administration in health care administration, and a master’s in International relations.
Dr. Nour Shamas
WHO Task Force of Antimicrobial Resistance (AMR) Survivors
Dr. Nour Shamas is a Lebanese infectious diseases and antimicrobial stewardship (AMS) clinical pharmacist with an MSc in Global Health policy. She has experience working in various healthcare settings in the USA, Cambodia and Saudi Arabia, and has 8 years’ experience leading hospital AMS programs. She recently consulted with the WHO on scaling up hospital AMS and developing AMS centers of excellence in the Eastern Mediterranean and is also on the WHO Task Force of AMR survivors as a carer for her mother who has survived an antimicrobial resistant infection.
Suzanne Naro
Policy Advisor, AMR Policy Accelerator
Suzanne Naro leads policy research projects to support governments and public health organizations to design policies on antimicrobial resistance. Her areas of expertise includes global health research, evidence-informed and equity-focused policy development, and facilitating policy dialogues to strengthen decision-making.
Her most recent policy research includes how national action plans on antimicrobial resistance can be more gender inclusive, and the barriers migrant and refugee communities face in accessing antimicrobials. Suzanne also provides practical facilitation support to national governments to strengthen the operationalization of interventions to mitigate antimicrobial resistance.
